Services Program for Residential Treatment for Pregnant and Postpartum Women

The Residential Treatment for Pregnant and Postpartum Women program is administered by the Substance Abuse and Mental Health Services Administration, an agency within the U.S. Department of Health and Human Services. SAMHSA’s mission focuses on reducing the impact of substance use and mental illness on America’s communities, and this funding opportunity reflects its strategic priorities of advancing recovery, expanding access to evidence-based treatment, and improving outcomes for vulnerable populations. The program is authorized under the Public Health Service Act and is designed to support comprehensive, family-centered treatment systems. The primary purpose of this program is to provide a full continuum of residential treatment services for pregnant and postpartum women experiencing substance use disorders, including those with co-occurring mental health conditions. The initiative emphasizes not only clinical treatment but also long-term recovery support, family stability, and improved maternal and infant health outcomes. Grantees are expected to deliver integrated services that include screening, assessment, individualized treatment planning, and coordinated care for both mothers and their children. The program also seeks to reduce maternal and infant mortality, increase abstinence from illicit substances, and minimize disruptions to family units. Funding is provided through discretionary federal grants with an estimated total program allocation of $5,250,000 and approximately ten awards anticipated. Each award may provide up to $525,000 per year for a project period of up to five years. Funds are intended to support direct service delivery, including residential treatment, recovery support services, case management, and supplemental services such as prenatal care, childcare, and workforce development support. However, funding restrictions apply, including prohibitions on certain activities such as harm reduction approaches as defined by SAMHSA guidance, and limitations on specific expenditures like non-recovery housing costs and certain medical treatments. Eligibility is limited to domestic public and private nonprofit entities, including states, territories, tribal organizations, political subdivisions, and community-based or faith-based organizations with demonstrated experience in delivering substance use disorder treatment services. Applicants must meet strict requirements related to licensing, accreditation, and service delivery experience, and must provide documentation of nonprofit status where applicable. Additionally, organizations that previously received funding under certain prior iterations of this program are not eligible to apply. A cost-sharing requirement is mandated, requiring non-federal contributions that vary by project year, beginning at a ratio of $1 for every $9 of federal funding in the first two years and increasing to $1 for every $3 in later years. The application process involves multiple components, including a project abstract, detailed project narrative, budget narrative, and a series of required attachments such as letters of commitment, timelines, and documentation of compliance and capacity. Applications are submitted through Grants.gov or eRA Commons, and applicants must maintain active registrations in federal systems such as SAM.gov. The review process includes an initial eligibility screening followed by a merit-based peer review that evaluates criteria such as need, implementation approach, use of evidence-based practices, organizational capacity, and data collection strategies. The application deadline for this funding opportunity is July 16, 2026, with awards expected to be announced by September 1, 2026, and project start dates anticipated for September 30, 2026. Applicants must also comply with ongoing reporting and performance measurement requirements if funded, including regular submission of programmatic and financial reports. SAMHSA provides technical assistance and may require participation in meetings throughout the project period. Key contacts for the program include Amy B. Smith for programmatic questions and designated offices for financial and review inquiries. Overall, this grant represents a significant federal investment in addressing substance use disorders among pregnant and postpartum women through comprehensive, evidence-based residential treatment models. It prioritizes integrated care, family preservation, and long-term recovery outcomes, while requiring strong organizational capacity, compliance with federal regulations, and alignment with SAMHSA’s strategic priorities.

Ensure strong alignment with SAMHSA strategic priorities and evidence-based practices; clearly demonstrate capacity and partnerships; provide detailed implementation and data collection plans; meet all compliance and licensing requirements